Limitations in manufacturer reporting of average sales price data for Part B drugs.
- Physical Description: 1 online resource (23 pages) : illustrations
- Publisher: [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2014.
|General Note:|| Title from title screen (viewed June 13, 2016).
|Bibliography, etc. Note:|| Includes bibliographical references.
Search for related items by subject
|Subject:||Centers for Medicare & Medicaid Services (U.S.) > Auditing.
Medicaid > Finance.
Drugs > Prices > United States.
Pharmaceutical policy > United States.